Are bisphosphonates ready for the adjuvant setting?
Korde
Larissa A
LA
Division of Oncology, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98119, USA. lkorde@u.washington.edu
Gralow
Julie R
JR
D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control*
D004164:Diphosphonates